S. Maxwell

The clinical of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no or

M. Jacobson, C. Benson, D. Wohl, 2013 .

Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030

C. Crumpacker, S. Spector, D. Jabs, 2009, HIV clinical trials.

Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization.

V. Stollar, C. Ruemmler, G. Winkler, 1989, Virology.

Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys

J. Hubbell, B. Sugarman, B. Hutchins, 2011, Gene Therapy.

The Clinical Impact of Continuing to Prescribe Antiretroviral Therapy in Patients with Advanced AIDS Who Manifest No Virologic or Immunologic Benefit

M. Jacobson, C. Benson, D. Wohl, 2013, PloS one.